TNSN00226A1 - Composes morpholiniques antagonistes du recepteur de la nk-1 - Google Patents

Composes morpholiniques antagonistes du recepteur de la nk-1

Info

Publication number
TNSN00226A1
TNSN00226A1 TNTNSN00226A TNSN00226A TNSN00226A1 TN SN00226 A1 TNSN00226 A1 TN SN00226A1 TN TNSN00226 A TNTNSN00226 A TN TNSN00226A TN SN00226 A TNSN00226 A TN SN00226A TN SN00226 A1 TNSN00226 A1 TN SN00226A1
Authority
TN
Tunisia
Prior art keywords
morpholinic
compounds
receptor antagonist
receptor
compound
Prior art date
Application number
TNTNSN00226A
Other languages
English (en)
French (fr)
Inventor
Maria Ballard Theresa
Sleight Andrew
Andrew Higgins Guy
Hoffmann Torsten
Maria Poli Sonia
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TNSN00226A1 publication Critical patent/TNSN00226A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
TNTNSN00226A 1999-11-29 2000-11-29 Composes morpholiniques antagonistes du recepteur de la nk-1 TNSN00226A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99123685 1999-11-29

Publications (1)

Publication Number Publication Date
TNSN00226A1 true TNSN00226A1 (fr) 2002-05-30

Family

ID=8239481

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN00226A TNSN00226A1 (fr) 1999-11-29 2000-11-29 Composes morpholiniques antagonistes du recepteur de la nk-1

Country Status (49)

Country Link
EP (1) EP1103545B1 (enExample)
JP (1) JP3480835B2 (enExample)
KR (1) KR100390117B1 (enExample)
CN (1) CN1152016C (enExample)
AR (1) AR033659A1 (enExample)
AT (1) ATE253561T1 (enExample)
AU (1) AU775292B2 (enExample)
BG (1) BG64622B1 (enExample)
BR (1) BRPI0005616B8 (enExample)
CA (1) CA2326529C (enExample)
CO (1) CO5251405A1 (enExample)
CZ (1) CZ299286B6 (enExample)
DE (2) DE60006340T2 (enExample)
DK (1) DK1103545T3 (enExample)
DO (1) DOP2000000106A (enExample)
EA (1) EA004404B1 (enExample)
ES (2) ES2208205T3 (enExample)
FR (1) FR2801590A1 (enExample)
GB (1) GB2356863A (enExample)
GC (1) GC0000151A (enExample)
GE (1) GEP20022763B (enExample)
GT (1) GT200000197A (enExample)
HR (1) HRP20000809A2 (enExample)
HU (1) HU224703B1 (enExample)
ID (1) ID28483A (enExample)
IL (1) IL139868A (enExample)
IS (1) IS2212B (enExample)
IT (1) IT1320120B1 (enExample)
JO (1) JO2298B1 (enExample)
MA (1) MA26754A1 (enExample)
MX (1) MXPA00011672A (enExample)
MY (1) MY127426A (enExample)
NO (1) NO317264B1 (enExample)
NZ (1) NZ508386A (enExample)
OA (1) OA11513A (enExample)
PA (1) PA8507201A1 (enExample)
PE (1) PE20010901A1 (enExample)
PL (1) PL195957B1 (enExample)
PT (1) PT1103545E (enExample)
SG (1) SG97171A1 (enExample)
SI (1) SI1103545T1 (enExample)
SK (1) SK285373B6 (enExample)
SV (1) SV2002000227A (enExample)
TN (1) TNSN00226A1 (enExample)
TR (1) TR200302077T4 (enExample)
UA (1) UA70326C2 (enExample)
UY (1) UY26458A1 (enExample)
YU (1) YU73400A (enExample)
ZA (1) ZA200006964B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050398A2 (en) 1999-02-24 2000-08-31 F. Hoffmann-La Roche Ag Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
ES2226622T3 (es) * 1999-02-24 2005-04-01 F. Hoffmann-La Roche Ag Derivados de 4-fenil piridina y su empleo como antagonistas del receptor nk-1.
RS50932B (sr) * 2000-07-14 2010-08-31 F. Hoffmann-La Roche Ag. N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora
TWI287003B (en) * 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives
US20030083345A1 (en) * 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
EP1472377A2 (en) * 2002-01-31 2004-11-03 F. Hoffmann-La Roche Ag Genetic polymorphisms in the preprotachykinin gene
JP4490421B2 (ja) 2003-07-03 2010-06-23 エフ．ホフマン−ラ ロシュ アーゲー 統合失調症を処置するデュアルｎｋ１／ｎｋ３アンタゴニスト
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
CN1984891B (zh) 2004-07-06 2012-08-08 弗·哈夫曼-拉罗切有限公司 用作合成nk-1受体拮抗剂的中间体的甲酰胺吡啶衍生物的制备方法
EP2281556A1 (en) 2005-02-25 2011-02-09 F. Hoffmann-La Roche AG Tablets with improved drugs substance dispersibility
BRPI0609699A2 (pt) 2005-03-23 2010-04-20 Hoffmann La Roche metabolitos para antatonistas de nk-1 para êmese
WO2007039420A1 (en) * 2005-09-23 2007-04-12 F. Hoffmann-La Roche Ag Novel dosage formulation
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
PE20151900A1 (es) 2013-03-15 2016-01-20 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina
RU2673084C2 (ru) 2013-11-08 2018-11-22 Киссеи Фармасьютикал Ко., Лтд. Производное карбоксиметилпиперидина
WO2015120133A1 (en) 2014-02-07 2015-08-13 Global Blood Therapeutics, Inc. Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
TWI649307B (zh) 2014-05-07 2019-02-01 日商橘生藥品工業股份有限公司 Cyclohexylpyridine derivative
KR101948238B1 (ko) 2016-08-19 2019-02-14 (주)케어젠 미녹시딜과 펩타이드의 결합체
KR102328682B1 (ko) 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT533280E (pt) * 1991-09-20 2001-01-31 Glaxo Group Ltd Novas utilizacoes medicas para antagonistas de taquiquinina
CA2099233A1 (en) * 1992-06-29 1993-12-30 Conrad P. Dorn Morpholine and thiomorpholine tachykinin receptor antagonists
IL111960A (en) * 1993-12-17 1999-12-22 Merck & Co Inc Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
KR100286412B1 (ko) * 1993-12-29 2001-04-16 더블유. 지. 콜 치환된 모르폴린 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
TW394773B (en) * 1995-03-24 2000-06-21 Takeda Chemical Industries Ltd Cyclic compounds for antagonizing tachykinin receptor, substance p receptor and neurokinin a receptor, their production and pharmaceutical composition
US5972938A (en) * 1997-12-01 1999-10-26 Merck & Co., Inc. Method for treating or preventing psychoimmunological disorders
ES2226622T3 (es) * 1999-02-24 2005-04-01 F. Hoffmann-La Roche Ag Derivados de 4-fenil piridina y su empleo como antagonistas del receptor nk-1.
US6303790B1 (en) * 1999-11-29 2001-10-16 Hoffman-La Roche Inc. Process for the preparation of pyridine derivatives
RS50932B (sr) * 2000-07-14 2010-08-31 F. Hoffmann-La Roche Ag. N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora
TWI287003B (en) * 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives

Also Published As

Publication number Publication date
PL195957B1 (pl) 2007-11-30
ATE253561T1 (de) 2003-11-15
BR0005616A (pt) 2001-07-17
AU775292B2 (en) 2004-07-29
GB2356863A (en) 2001-06-06
IS2212B (is) 2007-02-15
NZ508386A (en) 2003-02-28
CN1297888A (zh) 2001-06-06
EA004404B1 (ru) 2004-04-29
IL139868A (en) 2009-09-01
DE10058310A1 (de) 2001-05-31
CZ299286B6 (cs) 2008-06-04
SI1103545T1 (en) 2004-02-29
BRPI0005616B8 (pt) 2021-07-06
UY26458A1 (es) 2001-05-31
EA200001114A2 (ru) 2001-08-27
AU7178700A (en) 2001-05-31
BRPI0005616B1 (pt) 2017-12-12
AR033659A1 (es) 2004-01-07
MY127426A (en) 2006-11-30
EP1103545A1 (en) 2001-05-30
HU224703B1 (en) 2006-01-30
HK1036759A1 (en) 2002-01-18
ITMI20002575A1 (it) 2002-05-29
CZ20004399A3 (cs) 2001-07-11
HU0004725D0 (enExample) 2001-02-28
PL344147A1 (en) 2001-06-04
DK1103545T3 (da) 2004-03-15
ES2208205T3 (es) 2004-06-16
IL139868A0 (en) 2002-02-10
ID28483A (id) 2001-05-31
PE20010901A1 (es) 2001-09-20
SK17932000A3 (sk) 2001-11-06
CO5251405A1 (es) 2003-02-28
SK285373B6 (sk) 2006-12-07
SG97171A1 (en) 2003-07-18
NO317264B1 (no) 2004-09-27
DE60006340T2 (de) 2004-09-09
CA2326529C (en) 2009-12-22
ZA200006964B (en) 2001-06-05
FR2801590A1 (fr) 2001-06-01
JO2298B1 (en) 2005-09-12
DOP2000000106A (es) 2002-07-30
BG64622B1 (bg) 2005-09-30
GB0028566D0 (en) 2001-01-10
EP1103545B1 (en) 2003-11-05
UA70326C2 (en) 2004-10-15
JP3480835B2 (ja) 2003-12-22
BG104992A (en) 2001-11-30
NO20006012L (no) 2001-05-30
MXPA00011672A (es) 2002-08-20
GT200000197A (es) 2002-05-22
HRP20000809A2 (en) 2001-12-31
IT1320120B1 (it) 2003-11-18
KR20010051983A (ko) 2001-06-25
DE60006340D1 (de) 2003-12-11
NO20006012D0 (no) 2000-11-28
PA8507201A1 (es) 2002-02-21
PT1103545E (pt) 2004-03-31
ES2171134A1 (es) 2002-08-16
JP2001151754A (ja) 2001-06-05
TR200302077T4 (tr) 2004-01-21
MA26754A1 (fr) 2004-12-20
OA11513A (fr) 2004-02-03
IS5725A (is) 2001-05-29
YU73400A (sh) 2003-02-28
KR100390117B1 (ko) 2003-07-04
CA2326529A1 (en) 2001-05-29
EA200001114A3 (ru) 2001-12-24
SV2002000227A (es) 2002-02-05
HUP0004725A2 (hu) 2002-04-29
GEP20022763B (en) 2002-08-26
GC0000151A (en) 2005-06-29
CN1152016C (zh) 2004-06-02

Similar Documents

Publication Publication Date Title
TNSN00226A1 (fr) Composes morpholiniques antagonistes du recepteur de la nk-1
MA27557A1 (fr) Derives d'indolyle pyrazinone utiles pour le traitement des maladies et des troubles hyperproliferants associes a l'angiogenese
ATE172460T1 (de) 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
MA26994A1 (fr) Quinazolines en tant qu'inhibiteurs de la mmp-13
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DE60220441D1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
EP1048659A4 (en) RETINOID RECEPTOR AGONISTS
EP1040831A3 (en) Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
ATE219077T1 (de) Endothelin antagoniste
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
TNSN02009A1 (fr) Pyrimidinones bicycliques condensees nouvelles, inhibitrices de mmp, et compositions les contenant.
EA199700111A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина
NO963064D0 (no) Behandling av normotensive glaukoma med angiotensin-II-antagonister
DE69734321D1 (de) Non-peptidische vasopressin via antagonisten
JO2321B1 (en) 4-phenyl-pyridine derivatives
ATE304530T1 (de) Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen
EP1534696A4 (en) THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF DYSLIPIDO MINIIDES
TNSN01175A1 (fr) Derives de piperidines antagonistes selectives de sous- types de recepteurs de nmda, et compositions les contenant.
BR9813208A (pt) Antagonista receptor de vitronectina
DE69614149D1 (de) Chinolinderivate als antimalariamittel
EA200201158A1 (ru) Бициклические циклогексиламины и их применение в качестве антагонистов nmda-рецепторов
DK0978284T3 (da) Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister
BR9809848A (pt) Composição
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3